Tenderwize
Tender search

Contractor

ROCHE FARMA, S.A

ESP / Madrid / 28042

Identifier:A08023145

Total awarded

€169M

Award notices won

32

Lots won

78

Last award

Aug 13, 2026

Awarded lots

LotCPVContract natureAward valueEstimated valuePlaceAward criteria

LOT-0001 / 1 - L1_ASOCIACIÓN PERTUZUMAB (DOE)/TRASTUZUMAB (DOE)

Pharmaceutical products

supplies€29.5M-

ESP

price

LOT-0006 / 6 - L6_TRASTUZUMAB EMTANSINA (DOE)

Pharmaceutical products

supplies€19.5M-

ESP

price

LOT-0003 / 3 - L3_FARICIMAB (DOE)

Pharmaceutical products

supplies€18.2M-

ESP

price

LOT-0004 / 4 - L4_GLOFITAMAB (DOE)

Pharmaceutical products

supplies€17.1M-

ESP

price

LOT-0005 / 5 - L5_OBINUTUZUMAB (DOE)

Pharmaceutical products

supplies€9.81M-

ESP

price

LOT-0002 / 2 - L2_EMICIZUMAB (DOE)

Pharmaceutical products

supplies€7.97M-

ESP

price

LOT-0015 / OCRELIZUMAB 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSIÓN

Antineoplastic and immunomodulating agents

supplies€7.43M€22.9M

-

price

LOT-0002 / LOTE DOS–ASOCIACIÓN DE PERTUZUMAB (DOE) Y TRASTUZUMAB (DOE)

Pharmaceutical products

supplies€4.86M-

ESP

price

LOT-0001 / ATEZOLIZUMAB 1.200 MG/20 ML 1 VIAL / ATEZOLIZUMAB 1.875 MG/15 ML 1 VIAL

Antineoplastic agents

supplies€4.72M€10.4M

ESP / Santiago de Compostela

price / 100%

LOT-0001 / Suministro de Entrectinib (DOE)

Pharmaceutical products

supplies€4.67M-

-

price

Show 68 more rows

LOT-0016 / PERTUZUMAB 420 MG VIAL CONCENTRADO PARA SOLUCION PARA PERFUSION

Antineoplastic and immunomodulating agents

supplies€4.4M€1.35M

-

price

LOT-0000 / Suministro del medicamento Phesgo 600 mg/600 mg Solución para inyección 1 vial de 10 ml Principio activo Pertuzumab/Trastuzumab, de cuantía indeterminada (Disp. Adicional 33 de la Ley 9 /2017 de Contratos del S. Público)mediante procedimiento negociado sin publicidad y tramitación ordinaria con destino el Serv. de Farmacia del Hospital Universitario Ntra Sra de Candelaria

Other therapeutic products

Various medicinal products

supplies€3.9M-

-

price / 100%

LOT-0026 / ATEZOLIZUMAB 1200 MG VIAL CONCENTRADO PARA SOLUCION PARA PERFUSIÓN

Antineoplastic and immunomodulating agents

supplies€2.99M€1.63M

-

price

LOT-0001 / 1 - TRASTUZUMAB EMTANSINA (DOE)

Pharmaceutical products

supplies€2.94M-

-

price

LOT-0018 / Emicizumab 150 mg/1ml (150mg/ml) vial sc

Various medicinal products

supplies€2.69M€5.92M

ESP

price / 100%

LOT-0011 / TRASTUZUMAB 600 MG VIAL SOLUCION INYECTABLE SUBCUTANEA

Medicinal products for the blood, blood-forming organs and the cardiovascular system

supplies€2.55M€8.5M

-

price

LOT-0012 / TRASTUZUMAB EMTANSINA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Antineoplastic and immunomodulating agents

supplies€1.64M€7.33M

-

price

LOT-0015 / Emicizumab 60 mg/0,4ml (150mg/ml) vial sc

Various medicinal products

supplies€1.59M€3.5M

ESP

price / 100%

LOT-0001 / LOTE 1.Vabysmo 120 mg/ml solución para inyeccion en jeringa precargada

Ophthalmologicals

supplies€1.51M-

ESP

price

LOT-0013 / TRASTUZUMAB EMTANSINA 160 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Antineoplastic and immunomodulating agents

supplies€1.41M€3.51M

-

price

LOT-0003 / SATRALIZUMAB 120 MG 1 JERINGA PRECARGADA 1ML SOLUCION INYECTABLE

Antineoplastic and immunomodulating agents

supplies€1.28M€1.07M

-

price

LOT-0000 / Suministro de FARICIMAB 120 MG/ML 0,24 ML Vial (VABYSMO) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.

Pharmaceutical products

supplies€1.07M€1.83M

ESP / Madrid

cost

LOT-0001 / ALECTINIB 150 MG CAPSULAS

Antineoplastic and immunomodulating agents

supplies€980,241€1.73M

-

price

LOT-0008 / EMICIZUMAB 150 MG VIAL 1 ML

Medicinal products for the blood, blood-forming organs and the cardiovascular system

supplies€915,270€475,940

-

price

LOT-0002 / 2 - OBINUTUZUMAB (DOE)

Pharmaceutical products

supplies€872,928-

-

price

LOT-0018 / PERTUZUMAB 600MG/TRASTUZUMAB 600 MG SOLUCION PARA INYECCION VIAL 10 ML

Antineoplastic and immunomodulating agents

supplies€833,464€1.19M

-

price

LOT-0001 / Pertuzumab/Trastuzumab 600 mg/600 mg inyectable 10 ml

Pharmaceutical products

supplies€825,125€1.4M

ESP / Leganés (Madrid)

price

LOT-0019 / Atezolizumab 840 mg/14 ml vial perf iv

Various medicinal products

supplies€758,719€1.67M

ESP

price / 100%

LOT-0010 / EMICIZUMAB 60MG/0,4 ML (150 MG/ML) VIAL

Medicinal products for the blood, blood-forming organs and the cardiovascular system

supplies€732,220€14.3M

-

price

LOT-0014 / RITUXIMAB 1400MG VIAL 1400 MG/11,7 ML SOLUCION PARA INYECCION SUBCUTANEA

Antineoplastic and immunomodulating agents

supplies€624,371€38.6M

-

price

LOT-0001 / MEDICAMENTOS EXCLUSIVOS

Various medicinal products

supplies€619,230-

-

price

LOT-0000 / Suministro del producto farmacéutico (Risdiplam), para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.

Various medicinal products

supplies€614,579-

-

price / 100%

LOT-0005 / RISDIPLAM 0,75MG/ML SOLUCION ORAL

Other nervous system medicinal products

supplies€606,492€2.27M

-

price

LOT-0000 / El objeto del contrato viene determinado por el suministro del fármaco denominado "PHESGO 600 MG/600 MG SC C/1".

Various medicinal products

supplies€562,586-

-

price / 100%

LOT-0000 / Suministro del medicamento Polivy (Principio activo Polatuzumab 30 mg vial perf IV) de cuantia indeterminada (Disposición adicional 33 de la Ley 9/2017 de Contratos del Sector Público, mediante procedimiento negociado sin publicidad y tramitación ordinaria, con destino el servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria, a realizar por la empresa Roche Farma S.A.

Various medicinal products

supplies€472,483-

-

price / 100%

LOT-0001 / 1 - HEMLIBRA

Pharmaceutical products

supplies€457,635€457,650

ESP / Logroño

cost / 100%

LOT-0047 / Lote 47 - Fármacos exclusivos de ROCHE FARMA S.A

Pharmaceutical products

supplies€454,854€1.23M

ESP / Barcelona

price

LOT-0001 / MEDICAMENTOS EXCLUSIVOS

Various medicinal products

supplies€447,450-

-

price

LOT-0006 / OBINUTUZUMAB 1000 MG VIAL CONCENTRADO PARA SOLUCION PARA PERFUSIÓN 40 ML

Antineoplastic and immunomodulating agents

supplies€436,464€1.67M

-

price

LOT-0017 / Emicizumab 105 mg/0,7ml (150mg/ml) vial sc

Various medicinal products

supplies€435,669€958,472

ESP

price / 100%

LOT-0001 / Ocrevus vial 300 mg

Endocrine therapy medicinal products

supplies€412,820-

-

price

LOT-0000 / Suministro de medicamento exclusivo Emicizumab

Medical equipments, pharmaceuticals and personal care products

Pharmaceutical products

supplies€390,273-

-

quality / 10%

LOT-0000 / Suministro de medicamentos exclusivos de la empresa ROCHE FARMA, S.A. que se detallan en el pliego de prescripciones técnicas con destino a los pacientes del INGESA en el Área Sanitaria de Melilla

Pharmaceutical products

supplies€371,538-

ESP

price / 100%

LOT-0002 / COBIMETINIB 20 MG COMPRIMIDOS

Antineoplastic and immunomodulating agents

supplies€331,782€6.63M

-

price

LOT-0001 / Risdiplam 60mg/80ml oral

Various medicinal products

supplies€327,506€327,506

ESP

price / 100%

LOT-0007 / EMICIZUMAB 105MG/0,7ML (150MG/ML) VIAL

Medicinal products for the blood, blood-forming organs and the cardiovascular system

supplies€320,345€4.76M

-

price

LOT-0001 / Ocrelizumab

Immunosuppressive agents

supplies€309,615€681,153

ESP / Madrid

price / 50%

LOT-0003 / 3 - OCREVUS

Pharmaceutical products

supplies€309,615€309,615

ESP / Logroño

cost / 100%

LOT-0000 / Suministro farmacéutico del principio activo Pertuzumab/Trastuzumab.

Various medicinal products

supplies€305,423-

-

price / 100%

LOT-0017 / PERTUZUMAB 1200MG/TRASTUZUMAB 600 MG SOLUCION PARA INYECCION VIAL 15 ML

Antineoplastic and immunomodulating agents

supplies€259,000€22.9M

-

price

LOT-0000 / Suministro de medicamentos exclusivos que se detallan en el pliego de prescripciones técnicas con destino a los pacientes del Servicio de Farmacia del Hospital Universitario de Ceuta.

Medical equipments, pharmaceuticals and personal care products

Pharmaceutical products

supplies€235,213-

ESP

quality / 100%

LOT-0001 / LOTE UNO– FARICIMAB (DOE)

Pharmaceutical products

supplies€223,725-

ESP

price

LOT-0004 / VISMODEGIB 150 MG CAPSULAS

Antineoplastic and immunomodulating agents

supplies€206,546€3.27M

-

price

LOT-0002 / Faricimab 120 mg/ml solución inyectable

Various medicinal products

supplies€186,139€186,139

ESP

price / 100%

LOT-0002 / 2 - KADCYLA

Pharmaceutical products

supplies€169,830€169,830

ESP / Logroño

cost / 100%

LOT-0002 / Pertuzumab/Trastuzumab 1200 mg/600 mg inyectable 15 ml

Pharmaceutical products

supplies€116,550€198,135

ESP / Leganés (Madrid)

price

LOT-0000 / Acuerdo Marco de Suministro de medicamento exclusivo EMICIZUMAB para los Órganos Periféricos del Servicio Cántabro de Salud (AM SCS 2022/76)

Medical equipments, pharmaceuticals and personal care products

Pharmaceutical products

supplies€97,568-

-

quality / 10%

LOT-0003 / Epoetina beta 75 MCG/0,3 ML

Various medicinal products

supplies€93,493€93,520

ESP

price / 100%

LOT-0009 / EMICIZUMAB 30 MG/ML VIAL 1 ML

Medicinal products for the blood, blood-forming organs and the cardiovascular system

supplies€91,527€3.81M

-

price

LOT-0002 / Epotina Beta

Medicinal products for the blood, blood-forming organs and the cardiovascular system

supplies€90,000€153,000

ESP

price / 100%

LOT-0002 / Pertuzumab 1200 mg/Trastuzumab 600 mg SC

Various medicinal products

supplies€87,413€87,413

ESP

price / 100%

LOT-0016 / Emicizumab 30 mg/1 ml (30mg/ml) vial sc

Various medicinal products

supplies€80,544€177,196

ESP

price / 100%

LOT-0004 / Epoetina beta 100 MCG/0,3 ML

Various medicinal products

supplies€67,144€67,144

ESP

price / 100%

LOT-0021 / DORNASA ALFA 2500 UI/2,5 ML SOLUCION INHALACION NEBULIZADOR

Antineoplastic and immunomodulating agents

supplies€52,499€3.06M

-

price

LOT-0002 / Epoetina beta 50 MCG/0,3 ML

Various medicinal products

supplies€47,640€47,640

ESP

price / 100%

LOT-0006 / Epoetina beta 150 MCG/0,3 ML

Various medicinal products

supplies€28,720€28,720

ESP

price / 100%

LOT-0001 / Epoetina beta 30 MCG/0,3 ML

Various medicinal products

supplies€23,316€23,316

ESP

price / 100%

LOT-0007 / Epoetina beta 200 MCG/0,3 ML

Various medicinal products

supplies€18,765€18,765

ESP

price / 100%

LOT-0005 / Epoetina beta 120 MCG/0,3 ML

Various medicinal products

supplies€17,950€17,950

ESP

price / 100%

LOT-0008 / Epoetina beta 250 MCG/0,3 ML

Various medicinal products

supplies€8,620€8,620

ESP

price / 100%

LOT-0001 / ALECENSA 150 MG, 224 capsulas

Medical equipments, pharmaceuticals and personal care products

supplies--

-

price

LOT-0002 / PHESGO 600 mg/600 mg , 1 vial de 10 ml

Medical equipments, pharmaceuticals and personal care products

supplies--

-

price

LOT-0000 / Lote 1 SUM

Pharmaceutical products

supplies--

ESP

price

LOT-0001 / HERCEPTIN 600 MG, 1 VIAL

Medical equipments, pharmaceuticals and personal care products

supplies--

-

price

LOT-0002 / MABTHERA 1400 MG, 1 VIAL

Medical equipments, pharmaceuticals and personal care products

supplies--

-

price

LOT-0004 / HEMLIBRA 105 MG/0,7 ML, 1 VIAL 0,7 ML

Medical equipments, pharmaceuticals and personal care products

supplies--

-

price

LOT-0005 / EVRYSDI 0,75 MG/ML POLVO SOL ORAL 1 FR 80 ML

Medical equipments, pharmaceuticals and personal care products

supplies--

-

price

LOT-0027 / VEMURAFENIB 240 MG COMPRIMIDOS RECUBIERTOS

Antineoplastic and immunomodulating agents

supplies--

-

price

Award tenders

TenderBuyerPublication dateProcedureAward dateAwarded to contractorLots won
Suministro de la asociación de Pertuzumab (DOE) y Trastuzumab (DOE), Emicizumab (DOE), Faricimab (DOE), Glofitamab (DOE), Obinutuzumab (DOE) y Trastuzumab emtansina (DOE)

565980-2026

OSAKIDETZA - Servicio Vasco de Salud - Organización Central

Aug 13, 2026neg-wo-callAug 11, 2026€102M6
Suministro de medicamentos exclusivos de la empresa ROCHE FARMA, S.A. que se detallan en el pliego de prescripciones técnicas con destino a los pacientes del INGESA en el Área Sanitaria de Melilla

563098-2026

Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria

Aug 12, 2026neg-wo-callAug 10, 2026€371,5381
Suministro de Medicamentos Epoetinas para varias comunidades autónomas centros del Ingesa

515848-2026

Servicio Murciano de Salud - Junta de Compras

Jul 26, 2026neg-wo-callJul 21, 2026€2.51M1
Suministro de medicamentos exclusivos que se detallan en el pliego de prescripciones técnicas con destino a los pacientes del Servicio de Farmacia del Hospital Universitario de Ceuta.

504491-2026

Gerencia de Atención Sanitaria del Instituto Nacional de Gestión Sanitaria en Ceuta

Jul 20, 2026neg-wo-callJul 15, 2026€235,2131
suministro de los principios activos denominados "EPOETINA BETA PEGILADA " para el Hospital Universitario de Gran Canaria Dr.Negrín.

482701-2026

Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín

Jul 12, 2026neg-wo-callJul 05, 2026€305,6488
Suministro de adquisición del Vabysmo 120 mg/ml solución para inyección en jeringa precargada y Vabysmo 120 mg/ml solución inyectable para inyección, (Faricimab), para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.

465708-2026

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

Jul 06, 2026neg-wo-callJul 05, 2026€1.51M1
La contratación, mediante Acuerdo Marco con varios empresarios, del suministro sucesivo de los medicamentos de inmunoterapia oncológica para los centros hospitalarios del Servicio Gallego de Salud

435978-2026

SERGAS. SERVIZO GALEGO DE SAÚDE.

Jun 24, 2026neg-wo-callJun 15, 2026€11M1
Suministro del medicamento Phesgo 600 mg/600 mg Solución para inyección 1 vial de 10 ml Principio activo Pertuzumab/Trastuzumab, de cuantía indeterminada (Disp. Adicional 33 de la Ley 9 /2017 de Contratos del S. Público)mediante procedimiento negociado sin publicidad y tramitación ordinaria con destino el Serv. de Farmacia del Hospital Universitario Ntra Sra de Candelaria

501437-2024

Consejería de Sanidad del Gobierno de Canarias

Aug 20, 2024neg-wo-callAug 12, 2024€3.9M1
ADQUISICIÓN DE FÁRMACOS PARA EL TRATAMIENTO DEL CÁNCER DE MAMA DE DISTRIBUCIÓN EXCLUSIVA EN EL HOSPITAL UNIVERSITARIO SEVERO OCHOA

498892-2024

HOSPITAL UNIVERSITARIO SEVERO OCHOA

Aug 19, 2024neg-wo-callAug 11, 2024€979,3422
FARM F101-2024

462634-2024

SERVICIO NAVARRO SALUD-OSASUNBIDEA

Jul 31, 2024neg-wo-call-€2.44M2
Show 22 more rows
PNSP SUM 24-008

447883-2024

Ente Público Hospital Universitario de Fuenlabrada

Jul 24, 2024neg-wo-call-€447,4501
Suministro del producto farmacéutico (Risdiplam), para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.

445553-2024

Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil

Jul 23, 2024neg-wo-callJul 18, 2024€614,5791
Suministro de productos farmacéuticos (Risankizumab, Faricimab y Maribavir), para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.

386996-2024

Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil

Jun 28, 2024neg-wo-callJun 19, 2024€186,1391
PNSP SUM 24-002

362772-2024

Ente Público Hospital Universitario de Fuenlabrada

Jun 19, 2024neg-wo-call-€619,2301
Suministro de medicamento exclusivo Emicizumab

377482-2024

Servicio Cántabro de Salud

Jun 26, 2024restrictedJun 17, 2024€375,2631
Suministro del medicamento Polivy (Principio activo Polatuzumab 30 mg vial perf IV) de cuantia indeterminada (Disposición adicional 33 de la Ley 9/2017 de Contratos del Sector Público, mediante procedimiento negociado sin publicidad y tramitación ordinaria, con destino el servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria, a realizar por la empresa Roche Farma S.A.

365011-2024

Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria

Jun 20, 2024neg-wo-callJun 17, 2024€472,4831
Suministro de FARICIMAB 120 MG/ML 0,24 ML Vial (VABYSMO) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.

375904-2024

HOSPITAL CLINICO SAN CARLOS

Jun 25, 2024neg-wo-callJun 04, 2024€1.83M1
Suministro de medicamentos de uso humano Tipo II (Exclusivos) con destino al Servicio Canario de la Salud

313933-2024

Dirección General de Recursos Económicos del Servicio Canario de la Salud

May 28, 2024neg-wo-callMay 21, 2024€56.2M5
Adquisición del medicamento Ocrelizumab para el Hospital Universitario Infanta Leonor.

299877-2024

Hospital Universitario Infanta Leonor

May 22, 2024neg-wo-callMay 20, 2024€309,6151
Suministro de Entrectinib (DOE)

304795-2024

OSAKIDETZA - Servicio Vasco de Salud - Organización Central

May 23, 2024neg-wo-callMay 16, 2024€4.67M1
Suministro farmacéutico del principio activo Pertuzumab/Trastuzumab.

294670-2024

Gerencia de Servicio Sanitarios de Fuerteventura

May 21, 2024neg-wo-callMay 14, 2024€305,4231
Suministro de Trastuzumab emtansina (DOE) y Obinutuzumab(DOE)

285095-2024

OSAKIDETZA - Servicio Vasco de Salud - Organización Central

May 15, 2024neg-wo-callMay 12, 2024€3.82M2
SUMINISTRO DE LOS MEDICAMENTOS EXCLUSIVOS HEMLIBRA (P.A. EMICIZUMAB), KADCYLA (P.A. TRASTUZUMAB EMTANSINA) Y OCREVUS (P.A. OCRELIZUMAB) PARA EL SERVICIO DE FARMACIA DEL HOSPITAL UNIVERSITARIO SAN PEDRO DE LOGROÑO, SERVICIO RIOJANO DE SALUD

270857-2024

Servicio Riojano de Salud

May 07, 2024neg-wo-callMay 05, 2024€937,0803
FARM F90-2024

222245-2024

SERVICIO NAVARRO SALUD-OSASUNBIDEA

Apr 16, 2024neg-wo-call--4
El objeto del contrato viene determinado por el suministro del fármaco denominado "PHESGO 600 MG/600 MG SC C/1".

237322-2024

Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín

Apr 22, 2024neg-wo-callApr 10, 2024€562,5861
Suministro de los medicamentos FARICIMAB (DOE) y la ASOCIACIÓN DE PERTUZUMAB (DOE) Y TRASTUZUMAB (DOE) para todas las organizaciones de servicios de Osakidetza y centros vinculados.

225009-2024

OSAKIDETZA - Servicio Vasco de Salud - Organización Central

Apr 16, 2024neg-wo-callApr 04, 2024€5.09M2
Acuerdo Marco de Suministro de medicamento exclusivo EMICIZUMAB para los Órganos Periféricos del Servicio Cántabro de Salud (AM SCS 2022/76)

205947-2024

Servicio Cántabro de Salud

Apr 08, 2024neg-wo-callApr 03, 2024€93,8161
SUMINISTRO DE FÁRMACOS EXCLUSIVOS Y/O NO SUSTITUÍBLES

241722-2024

Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau

Apr 23, 2024neg-wo-callMar 27, 2024€7.95M1
PNSP HUPA 10/24

253647-2024

HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS

Apr 29, 2024neg-wo-callMar 18, 2024€412,8201
El objeto del contrato viene determinado por el suministro de los principios activos denominados "RISDIPLAM 60MG/80ML ORAL" y"PERTUZUMAB 1200 MG / TRASTUZUMAB 600 MG SC".

120419-2024

Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín

Feb 27, 2024neg-wo-callFeb 21, 2024€87,4132
SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ALECTINIB, COBIMETINIB, SATRALIZUMAB, VISMODEGIB, RISDIPLAM, OBINUTUZUMAB, EMICIZUMAB, TRASTUZUMAB SUBCUTÁNEO, TRASTUZUMAB EMTANSINA

159291-2024

Servicio Murciano de Salud

Mar 15, 2024neg-wo-callFeb 12, 2024€28.3M21
Contrato de suministro (CCA. CBZGCWV)

286024-2024

SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA

May 15, 2024neg-wo-callNov 07, 2023€2.36M1

Company details

Identifiers

A08023145

Countries

ESP

Cities

Madrid

Post codes

28042

Owner nationalities

ESP

Size

large

About this contractor

ROCHE FARMA, S.A is a contractor that has been awarded public procurement contracts published through official European procurement systems.

This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.

FAQ

What information does this contractor profile contain?

This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.

What does Total Awarded mean?

Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.

Why can the awarded value differ from the total contract value?

A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.

What are Awarded Lots?

Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.

How often is this profile updated?

Contractor profiles are updated automatically when new procurement notices and contract award notices become available.

Why are some company details missing?

Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.

Understanding this contractor profile

This contractor profile is generated from publicly available procurement information published by contracting authorities.

The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.

Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.